Endogenously produced catecholamines improve the regulatory function of TLR9-activated B cells

Area of Science:

• Immunology
• Neuroimmunology
• Cellular Biology

Background:

• The sympathetic nervous system (SNS) influences immune balance via anti-inflammatory B cells.
• The self-regulatory mechanisms of B cells in modulating regulatory B cell (Breg) function remain unclear.

Purpose of the Study:

• To investigate if B cells can synthesize their own catecholamines.
• To understand the role of B cell-derived catecholamines in immune regulation and autoimmune diseases.

Main Methods:

• Stimulation of B cells with various activators to assess catecholamine synthesis.
• Analysis of tyrosine hydroxylase (TH) enzyme expression.
• Measurement of adrenergic receptors (ADRs), IL-10, PD-L1, and FasL levels.
• Assessment of Breg function in suppressing CD4 T cells.
• In vivo studies using a collagen-induced arthritis (CIA) mouse model.

Main Results:

• Toll-like receptor 9 (TLR9) stimulation up-regulates TH expression in B cells, enabling catecholamine synthesis.
• Upregulated TH correlated with increased ADRs, IL-10 production, and co-inhibitory ligands (PD-L1, FasL).
• Combined stimulation of ADRs and B cell receptor (BCR)/TLR9 enhanced Breg-mediated suppression of CD4 T cells.
• TH upregulation was observed in B cells from CIA mice, a model for rheumatoid arthritis (RA).

Conclusions:

• B cells possess an autonomous mechanism for modulating their regulatory functions through autocrine/paracrine signaling.
• This finding sheds light on B cell roles in autoimmune disease regulation and the interplay with the SNS.
• The study identifies a novel self-regulatory pathway in B cells impacting immune homeostasis.